April 3, 2018 / 7:28 AM / 19 days ago

BRIEF-Motif Bio Initiates NDA Rolling Submission For Iclaprim And Provides Business Update

April 3 (Reuters) - Motif Bio PLC:

* MOTIF BIO INITIATES NDA ROLLING SUBMISSION FOR ICLAPRIM AND PROVIDES BUSINESS UPDATE

* INITIATION OF A ROLLING SUBMISSION OF A NEW DRUG APPLICATION (NDA) TO U.S. FOOD & DRUG ADMINISTRATION (FDA) FOR ICLAPRIM

* NDA SUBMISSION IS EXPECTED TO BE COMPLETED DURING Q2 OF 2018. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below